通用定义下心肌损伤与心梗类别的心血管风险荟萃分析
本项个体患者数据荟萃分析纳入9个国家8个队列共120,734例疑似ACS患者,依据第四版心肌梗死通用定义进行中心裁定。结果显示1型心梗的MACE风险最高(sHR 4.82,95%CI 3.55-6.57),但2型心梗中非心血管死亡的竞争风险显著更高(非心血管死亡率60.1 vs 25.7/1000人年),可能削弱其MACE的表观风险。
要点
- 2型心梗患者非心血管死亡率(60.1/1000人年)远超1型心梗(25.7/1000人年),临床需同样重视非心脏原因。
- 急性和慢性心肌损伤的MACE风险均显著升高(sHR 3.24和3.03),不可简单视为良性改变。
- 1型心梗MACE率最高(55.2/1000人年),但四类心肌损伤/心梗均增加事件风险。
核心结论
- 所有心肌损伤与心梗类别均增加未来MACE(心梗或心血管死亡)风险,但2型心梗的表观风险因更强的非心血管死亡竞争风险而被削减。
研究设计与样本
- 系统检索MEDLINE、EMBASE、Central及Web of Science(2007年1月1日至2025年7月1日)前瞻性研究,进行个体患者数据荟萃分析。
- 纳入120,734例疑似ACS患者(中位年龄61.0岁,女性45.8%),来自9个国家8个队列,所有诊断经通用定义裁定,至少随访1年。
- 使用亚分布风险模型(sHR)竞争非心血管死亡风险,荟萃分析采用随机效应模型,主要终点为MACE(心梗或心血管死亡)。
主要发现
- 1型心梗占9.4%(n=11,298),MACE率55.2/1000人年,非心血管死亡率25.7/1000人年。
- 2型心梗占3.0%(n=3,609),MACE率51.7/1000人年,非心血管死亡率60.1/1000人年。
- 急性心肌损伤占4.9%(n=5,864),MACE率47.1/1000人年,非心血管死亡率67.0/1000人年。
- 慢性心肌损伤占4.7%(n=5,625),MACE率44.9/1000人年,非心血管死亡率46.9/1000人年。
- 与无心肌损伤者比,1型心梗MACE的sHR为4.82(95%CI 3.55-6.57),2型心梗为3.36(95%CI 2.92-3.86)。
临床怎么用
- 识别2型心梗时须积极评估并干预导致氧供需失衡的非心脏原因,因其非心血管死亡竞争风险极高。
- 急性和慢性心肌损伤不能被忽视,应作为心血管事件风险升高的重要标记进行二级预防管理。
局限性
- 1型心梗MACE风险的荟萃分析中异质性较高(I²=84%),提示各队列间效应量差异较大。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The Universal Definition classifies myocardial infarction (MI) by etiology, but its prognostic implications are uncertain. OBJECTIVES: The goal was to compare the rate and risk of recurrent MI or cardiovascular death among patients with myocardial injury and infarction classified according to the Universal Definition. METHODS: A systematic search of MEDLINE, EMBASE, Central, and Web of Science from January 1, 2007 to July 1, 2025 was performed to identify prospective studies where cardiac troponin was measured for suspected acute coronary syndrome, diagnoses were adjudicated using the Universal Definition, and both MI and cause-specific mortality were reported at a minimum of 1 year. Subdistribution HRs were derived to account for the competing risk of noncardiovascular death. Meta-analysis was performed with random-effects models. The primary outcome was major adverse cardiovascular events (MACE), defined as MI or cardiovascular death. The secondary outcome was noncardiovascular death. RESULTS: We identified 17 studies of 9 cohorts from 9 countries, with individual patient-level data available in 8 cohorts. Among 120,734 patients (median age: 61.0 years; 45.8% women), type 1 MI occurred in 9.4% (n = 11,298), type 2 MI in 3.0% (n = 3,609), acute myocardial injury in 4.9% (n = 5,864), and chronic myocardial injury in 4.7% (n = 5,625). In patients with type 1 and type 2 MI, the MACE rate was 55.2 and 51.7 per 1,000 patient-years and the noncardiovascular death rate was 25.7 and 60.1 per 1,000 patient-years, respectively. Compared with those without myocardial injury, the risk of MACE (subdistribution HR) was 4.82 (95% CI: 3.55-6.57; I2 = 84%) and 3.36 (95% CI: 2.92-3.86; I2 = 0%), respectively. In patients with acute and chronic myocardial injury, the MACE rate was 47.1 and 44.9 per 1,000 patient-years and the noncardiovascular death rate was 67.0 and 46.9 per 1,000 patient-years, respectively. The risk of MACE was 3.24 (95% CI: 2.41-4.36; I2 = 59%) and 3.03 (95% CI: 2.53-3.62; I2 = 20%), respectively. CONCLUSIONS: All patients with myocardial injury and infarction are at increased risk of future cardiovascular events. However, in type 2 MI, this apparent risk is reduced by a substantially greater competing risk of noncardiovascular death. (PROSPERO Registration: CRD42023464836).
引用
- Boeddinghaus, Lopez-Ayala, Thurston, et al. Cardiovascular Risk Across Myocardial Injury and Infarction Categories Using the Universal Definition: An Individual Patient-Level Data Meta-Analysis. J Am Coll Cardiol. 2025. PMID: 41553312. doi:10.1016/j.jacc.2025.11.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。